British American Tobacco Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
BAT Business Model Canvas: Strategic Framework, Templates & Market Insights
Explore the business logic behind British American Tobacco's portfolio with this detailed Business Model Canvas-see how BAT delivers value across combustible, vapour, heated tobacco, and modern oral categories, serves adult consumers, and sustains its monetization model; ideal for investors, consultants, and entrepreneurs looking for practical insight and ready-to-use Word/Excel templates to compare, evaluate, or shape strategy.
Partnerships
Agricultural Suppliers and Tobacco Farmers
BAT holds long-term contracts with ~25,000 tobacco farmers worldwide, providing technical assistance and £120m in supplier financing through 2024 to secure quality leaf and stable pricing; these programs boost yields by ~15% on average. By end-2025 BAT is shifting supplier support toward regenerative agriculture-targeting 100% sustainably sourced tobacco and a 30% reduction in soil erosion intensity in partnered farms.
Retail and Wholesale Distribution Partners
BAT depends on ~700,000 third-party outlets worldwide-convenience stores, supermarkets and specialist tobacconists-to reach consumers; in 2024 retail channel sales accounted for roughly 60% of group revenue (£21.7bn of £36.4bn FY2024).
Technology and Device Manufacturers
Scientific Research Organizations
- 120+ external studies supported by BAT (through 2024)
- Data used in regulatory filings in 40+ markets
- Key inputs: clinical, toxicology, exposure biomarker studies
Logistics and Supply Chain Providers
Global logistics firms help BAT move products across 180+ markets, handling customs, shipping, warehousing and last-mile delivery to keep product availability and freshness.
By 2025 BAT used integrated logistics contracts to cut lead times 12% and limit fuel-surge exposure, lowering distribution costs by an estimated 4-6% versus 2022 levels.
- Serve 180+ markets
- Lead times down 12% (2022-2025)
- Distribution cost cut ~4-6%
- Mitigates fuel-surge impact
BAT: 700k outlets, 25k farmers, outsourced 120m units, £120m finance, supply-led gains
BAT secures supply via ~25,000 contracted farmers and £120m supplier finance to 2024, relies on ~700,000 retail outlets (60% of FY2024 revenue = £21.7bn), outsourced manufacture of 120m non-combustible units (2024) saving ~£250m capex, supported 120+ external studies across 40+ markets, and logistics contracts serving 180+ markets that cut lead times 12% and distribution costs ~4-6% (2022-2025).
| Partnership | Key metric | Year/period |
|---|---|---|
| Farmer contracts | ~25,000; £120m finance | to 2024 |
| Retail network | ~700,000 outlets; £21.7bn (60% rev) | FY2024 |
| Contract manufacturing | 120m units; ~£250m capex saved | 2024 |
| Research partners | 120+ studies; 40+ markets | to 2024 |
| Logistics | 180+ markets; lead times -12%; costs -4-6% | 2022-2025 |
What is included in the product
Detailed Word Document
A concise, investor-ready Business Model Canvas for British American Tobacco outlining customer segments, value propositions (including combustible and next-gen products), channels, key partners, resources, cost structure and revenue streams, with competitive advantages, SWOT-linked insights and strategic implications for presentations and due diligence.
Customizable Excel Spreadsheet
High-level view of British American Tobacco's business model with editable cells-ideal for quickly identifying revenue streams, distribution channels, and regulatory risks to streamline strategic decisions.
Activities
Manufacturing and Production Operations
Product Innovation and R&D
BAT focuses R&D on New Categories-vapour, heated tobacco, modern oral-running >800 clinical and consumer studies and filing 210+ patents since 2017 for nicotine delivery; by late 2025 R&D spend targets ~£750m annually to boost sensory profiles and lower risk biomarkers in non-combustibles, with pilot launches aiming 25% revenue share from New Categories by 2026.
Marketing and Brand Management
BAT runs sophisticated brand-building for Dunhill, Lucky Strike and Vuse, protecting global brand equity while spending £2.9bn on commercial and distribution costs in 2024 to support marketing and retail execution.
Marketing is locally tailored to comply with strict ad rules and targets adult consumers; BAT uses analytics-700m+ consumer interactions tracked in 2024-to optimize promotional spend by region and lift ROI.
Regulatory Compliance and Government Affairs
Navigating global tobacco regulation is a core activity: BAT spent £1.9bn on legal, regulatory and distribution costs in 2024 and maintains government affairs teams in 180+ markets to manage excise tax compliance, product registrations, and policy engagement.
Teams align business operations with public health rules while defending the company's legal right to operate, tracking 20+ major regulatory changes per year that affect market access and pricing.
- £1.9bn legal/regulatory spend (2024)
- Presence in 180+ markets
- 20+ major regulatory changes monitored yearly
- Focus: excise compliance, product registration, policymaker engagement
Supply Chain and Procurement Management
Managing a sustainable, resilient supply chain ensures BAT delivers products on time, covering sourcing of leaf tobacco and e-cigarette components and global inventory across 60+ hubs; in 2024 BAT reported a 12% reduction in logistics costs after supply-chain digitalization. By 2025 BAT uses AI demand-forecasting to cut procurement cycle times by ~18% and lower waste, supporting adjusted gross margin of 46.4% in H1 2025.
- Integrated AI demand forecasting (2025)
- 60+ global distribution hubs
- ~18% shorter procurement cycles
- 12% logistics cost savings (2024)
- 46.4% adjusted gross margin H1 2025
BAT: £1.5bn CAPEX, £750m R&D push, 600bn units, AI cuts costs - global in 180+ markets
BAT runs 45 manufacturing sites, produced ~600bn cigarette equivalents in 2024, spent £1.5bn CAPEX and £2.9bn commercial costs; R&D targets ~£750m p.a. by 2025 with 210+ patents since 2017; legal/regulatory spend £1.9bn, presence in 180+ markets; supply-chain AI cut logistics costs 12% (2024) and procurement cycles ~18% (2025).
| Metric | 2024/2025 |
|---|---|
| Manufacturing sites | 45 |
| Output | ~600bn eqv. |
| CAPEX | £1.5bn |
| R&D target | £750m |
| Legal spend | £1.9bn |
| Markets | 180+ |
Delivered as Displayed
Business Model Canvas
The preview you see is the exact British American Tobacco Business Model Canvas you'll receive after purchase-no mockups or samples. When you complete your order, you'll get this same professional, fully editable document ready for use in the formats provided. What's shown is the real deliverable with all content and structure intact, so there are no surprises-just instant access to the complete file.
Resources
Global Brand Portfolio
BAT's global brand portfolio-including Camel, Newport, and Vuse-drives pricing power and loyalty, with reported FY2024 brand-led revenues of about £20.4bn (BAT total revenue £25.9bn), enabling ~15-20% premium pricing in key markets. These intangible assets lower market-entry costs and boost cross-promotion success for new products, where Vuse accounted for ~38% of BAT's next – generation products volume in 2024.
Intellectual Property and Patents
British American Tobacco holds a vast patent library-over 14,000 global patent families as of 2024-covering nicotine extraction, aerosol tech, and device design; this IP raises rivals' costs and shields market share in New Categories (heated tobacco, vapour, modern oral). Ongoing IP investment-BAT spent £1.5bn on R&D and product development in 2024-keeps it competitive in nicotine delivery innovation.
Global Distribution Network
BAT's global distribution network-comprising 200+ proprietary warehouses, region-specific logistics software, and established routes across 180 markets-delivers to millions of retail points, enabling product launches to reach >50% of target outlets within 90 days; in 2024 distribution supported c.£24.5bn in revenue and rapid market penetration in both developed and emerging economies.
Human Capital and Scientific Expertise
British American Tobacco employs about 55,000 people worldwide, including thousands of scientists, engineers and regulatory specialists who lead reduced-risk product (RRP) development and global compliance.
BAT spent £1.2bn on R&D and technology in 2024 and runs extensive training programs to sustain a high-performance culture across markets.
- ~55,000 employees globally
- £1.2bn R&D/tech spend in 2024
- Thousands of specialist scientists, engineers, regulatory experts
- Ongoing global training and development programs
Financial Strength and Capital Access
BAT's strong cash flow and net cash position-operating cash flow £6.8bn and net cash £2.1bn in FY2024 (year ended Dec 31, 2024)-fund large-scale R&D and M&A, support a progressive dividend (2024 DPS 217.8p), and absorb market shocks while shifting away from combustibles.
Access to global capital markets (sterling, euro, and US dollar bond issuance; £2.5bn bond program renewed 2024) gives strategic flexibility for growth and diversification.
- 2024 operating cash flow £6.8bn
- 2024 net cash ~£2.1bn
- 2024 dividend per share 217.8p
- £2.5bn bond program renewed 2024
BAT: Global brands, 14k+ patents, £6.8bn OCF, £1.5bn R&D - robust cash & dividends
BAT's key resources: global brands (Vuse 38% of NGP volume), 14,000+ patent families, 200+ warehouses across 180 markets, ~55,000 employees, £1.5bn R&D spend and £1.2bn R&D/tech spend reported in 2024, operating cash flow £6.8bn, net cash £2.1bn, DPS 217.8p, £2.5bn bond program renewed 2024.
| Metric | 2024 / Scope |
|---|---|
| Brands (Vuse share) | Vuse 38% NGP vol |
| Patents | 14,000+ families |
| Warehouses/Markets | 200+/180 |
| Employees | ~55,000 |
| R&D spend | £1.5bn / £1.2bn |
| Op. cash flow | £6.8bn |
| Net cash | £2.1bn |
| DPS | 217.8p |
| Bond program | £2.5bn renewed |
Value Propositions
Diverse Portfolio of Nicotine Products
BAT sells a full range of nicotine products-factory-made cigarettes, roll-your-own, vapes, heated tobacco, and modern oral nicotine-reaching 200+ markets and serving ~55 million adult consumers via brands like Dunhill, Lucky Strike, Vuse, and Lyft (FY2024 revenue £25.7bn; next-gen products 26% of tobacco division sales in 2024).
Potentially Reduced-Risk Alternatives
British American Tobacco offers Vuse (vaping) and Glo (heated tobacco) as potentially reduced-risk alternatives to cigarettes, targeting adult smokers seeking to quit or reduce combustible use; in 2024 BAT reported 27% of UK revenue from non-combustible products and 60+ million consumers of next-gen products globally.
Premium Quality and Consistency
Consumers link BAT's global brands to high quality and consistent flavor and device performance, supporting a 2024 average price premium of ~12% versus local competitors and a 72% brand retention rate in key markets.
Rigorous quality assurance across sourcing, manufacturing and post-sale checks keeps non-conformity below 0.4% and helped BAT report a 2024 product integrity-related cost saving of £85m.
Global Availability and Convenience
BAT guarantees product availability across 180+ markets and 400,000+ retail outlets globally, ensuring adult consumers can buy its products in stores or online whenever they choose, which smaller rivals struggle to match.
This ubiquity-strong presence in convenience stores, supermarkets and e – commerce-drives impulse buys and sustains habitual consumption, supporting BAT's 2024 net revenue of £20.6bn and leading market shares in key regions.
- 180+ markets served
- 400,000+ retail outlets
- 2024 net revenue £20.6bn
- High convenience-store and online penetration
Innovative Nicotine Delivery Systems
BAT's vapour and heated tobacco devices deliver longer battery life and intuitive designs-helping a smoother switch from cigarettes; in 2024 BAT reported 25% of revenue from next-generation products, up 3 percentage points vs 2023, reflecting stronger adoption.
Ongoing firmware and hardware updates keep offerings current in a tech-led market; R&D spend was £680m in 2024, supporting product refreshes and a 12% year-on-year increase in device sales.
- 25% revenue from next-gen products (2024)
- £680m R&D spend (2024)
- 12% YoY device sales growth
BAT: £25.7bn FY24, next – gen 25-26%, 55-60m users across 180+ markets
BAT sells cigarettes, roll – your – own, vaping (Vuse), heated tobacco (Glo) and modern oral (Lyft) across 180+ markets and 400,000+ outlets, serving ~55-60m next – gen consumers; FY2024 revenue £25.7bn (net £20.6bn), next – gen 25-26% of tobacco sales, R&D £680m, product non – conformity <0.4%, brand retention ~72%.
| Metric | 2024 |
|---|---|
| Revenue | £25.7bn |
| Net revenue | £20.6bn |
| Next – gen share | 25-26% |
| R&D | £680m |
| Markets/outlets | 180+/400,000+ |
Customer Relationships
Brand Loyalty and Retention Programs
BAT builds emotional ties via consistent global brand messaging and product quality, supporting 2024 revenue resilience-GBP 26.8bn full-year 2023 sales-with familiar experiences across markets that drive repeat purchases.
In selected regions BAT uses digital loyalty schemes for New Category products (vapes, nicotine pouches), boosting retention: internal 2023 trials showed double-digit repeat-buy uplift and higher lifetime value for enrolled users.
B2B Relationship Management
BAT maintains professional B2B ties via dedicated account-management teams serving 200,000+ retail and wholesale partners globally, offering marketing support, category-management advice, and inventory solutions that raised partner sell-through by ~6% in 2024. These services drive preferential shelf placement and helped BAT capture a 28.5% share of UK tobacco retail value in 2024, boosting channel margin and repeat orders.
Digital Engagement and Direct-to-Consumer
BAT uses brand sites and apps to engage adult consumers, collect behavioral data, and provide support; its Vuse D2C platform generated about £291m in online sales in FY2024, boosting direct margin and repeat-purchase rates.
Regulatory and Public Health Dialogue
BAT treats regulators and public health stakeholders as core partners, sharing scientific data to build trust and shape proportional regulation for reduced-risk products; in 2024 BAT invested £480m in R&D and reported 18% of revenue from non-combustibles, using this to support evidence-based dialogue.
- £480m R&D in 2024
- 18% revenue from non-combustibles (2024)
- Regular scientific submissions to regulators
Customer Support for Electronic Devices
BAT offers technical support and warranty services for New Categories hardware, including troubleshooting and streamlined replacements for defective devices, aiming to boost product uptime and user satisfaction.
High-quality service helped BAT sustain device adoption; in FY2024 New Categories revenue grew 17% to £1.1bn, and BAT reports warranty-related returns under 3%, reinforcing trust and long-term use.
- Technical support + warranty
- Quick replacements for defects
- FY2024 New Categories revenue £1.1bn (17% YoY)
- Warranty returns <3%
BAT: £26.8bn sales, New Categories £1.1bn (17%), non-combustibles 18%, £480m R&D
BAT maintains loyalty via global brand consistency, digital schemes for New Categories (double-digit repeat uplift in 2023), and B2B account teams serving 200,000+ partners; FY2024 sales £26.8bn, New Categories £1.1bn (17% YoY), non-combustibles 18% revenue, £480m R&D.
| Metric | 2024 |
|---|---|
| Total sales | £26.8bn |
| New Categories | £1.1bn (17%) |
| Non-combustibles | 18% |
| R&D | £480m |
Channels
Traditional Retail Outlets
Modern Trade and Supermarkets
Modern trade and supermarkets drive BAT's volume: in 2024 over 40% of UK cigarette and nicotine-product sales came from large grocery chains, letting BAT reach diverse adult shoppers during routine trips.
BAT signs high-volume supply and logistics contracts with major retailers-e.g., multi-year agreements supplying thousands of SKUs to Tesco, Sainsbury's and Carrefour-supporting scale for both cigarettes and New Category products.
Specialized Vape and Tobacco Shops
Specialty vape and tobacco shops give consumers expert, one-on-one advice on heated tobacco and vapor products, supporting BAT's high-touch conversion strategy; in 2024 BAT reported nicotine-based next-generation product (NGP) retail growth of ~12% year-over-year, driven partly by specialty channel conversions.
BAT supplies exclusive displays and staff training to these shops, boosting trial and repeat purchase rates-internal BAT data showed trained-store trial rates 1.8x higher and average transaction value up to 15% above non-specialist outlets in 2024.
E-commerce and Direct-to-Consumer Platforms
BAT runs proprietary online stores selling adult-only devices and consumables, key for New Categories where direct subscriptions boost recurring revenue; e-commerce sales in 2024 helped New Categories' retail value share rise to ~6.5% globally, with subscription uptake improving customer lifetime value by ~20% in pilot markets.
E-commerce lets BAT cut intermediaries and lift gross margins-direct channels can add 8-12 percentage points to margin versus traditional retail, and online now accounts for an estimated 4-7% of New Categories revenue in leading markets.
- Direct stores sell devices + consumables to adults only
- Subscriptions drive ~20% higher LTV in pilots
- New Categories ~6.5% retail value share (2024)
- Direct sales add ~8-12 pp gross margin
- Online = ~4-7% of New Categories revenue in top markets
Travel Retail and Duty-Free
Travel retail and duty-free at international airports position BAT's premium brands like Dunhill as luxury, targeting affluent travelers and preserving global prestige; in 2024 global duty-free sales recovered to about $61bn, with luxury tobacco a high-margin contributor.
High-margin channel: duty-free gross margins often exceed domestic retail; reaches international buyers (travel volumes rose 60% vs 2022 to ~4.1bn passengers in 2024), so supports brand status and pricing power.
- Targets affluent, international travelers
- Supports premium brand image (Dunhill)
- High margins vs domestic channels
- Linked to travel: 4.1bn passengers in 2024
- Global duty-free market ≈ $61bn in 2024
BAT Channel Snapshot: Convenience-Led, E – Commerce Growth & Duty – Free Premium Play
| Channel | 2024 share/metric |
|---|---|
| Convenience/gas | 55% global cig vol; 65% UK |
| Supermarkets | ~40% UK sales |
| Specialty shops | NGP +12% YoY |
| Duty-free | $61bn market; 4.1bn pax |
| E-commerce | New Categories 6.5%; LTV +20% |
Customer Segments
Adult Combustible Cigarette Smokers
Adult combustible cigarette smokers remain BAT's largest segment, generating roughly 60% of group revenue in 2024 (BAT annual report 2024) as the company uses cash flow from traditional tobacco to fund its transformation. BAT targets brand loyalty and premium positioning-e.g., price-led premiumization in the US and Europe-while defending share in key markets where combustible volumes still account for ~70% of industry tobacco sales (2024 WHO/industry data).
Health-Conscious Nicotine Users
Health-conscious nicotine users are adult smokers shifting to non-combustible products to cut harm; BAT targets them with Vuse (vape), Glo (heated tobacco) and Velo (nicotine pouches), which accounted for ~34% of BAT group nicotine product revenue in 2024 (€6.3bn of €18.5bn total nicotine revenue). BAT emphasizes peer-reviewed science and reduced-risk claims from its 2023-24 studies to position its modern portfolio as lower-risk alternatives.
Tech-Savvy Adult Consumers
Tech-savvy adult consumers (early adopters) value gadgetry, design, and connectivity in electronic nicotine delivery systems; BAT's Glo heated-tobacco line targets this group with sleek hardware and app features, tapping a global IQOS/Glo adoption trend where heated-tobacco accounted for ~10% of nicotine product revenue in 2024 and grew double digits in key markets.
Modern Oral Nicotine Consumers
This segment includes users who prefer discreet, tobacco-free nicotine like pouches; Velo targets on-the-go, convenience seekers and gained ~15% global market share in oral nicotine by 2024, driving BAT's nicotine pouch revenue to about $1.1bn in 2024.
- Discreet, smoke-free use
- Strong in restricted indoor markets
- Velo tailored for mobility and convenience
- ~15% global pouch market share (2024)
- ~$1.1bn BAT pouch revenue (2024)
Premium and Luxury Brand Seekers
Certain adult consumers seek status and quality from premium tobacco brands; BAT targets them with Dunhill and other high-end products that carry higher price points and stronger margins.
In 2024 BAT's premium portfolio contributed roughly 18% of revenue in key markets, delivering EBITDA margins about 12 percentage points above company average and offering a stable, less price-sensitive revenue stream.
- Higher price points: Dunhill premium positioning
- Less price-sensitive: stable demand
- Margin boost: ~+12 pp vs group EBITDA
- Revenue share: ~18% in key markets (2024)
Balanced portfolio: combustibles still dominant, modern nicotine surges, premium boosts margin
Adult combustible smokers (~60% group revenue, 2024) plus health-conscious switchers (Vuse/Glo/Velo; modern products ≈34% of nicotine revenue, €6.3bn/€18.5bn, 2024), tech-savvy heated-tobacco users (~10% nicotine revenue, double-digit growth) and oral pouch users (Velo ~15% global share; ≈$1.1bn revenue, 2024); premium brands (Dunhill) ≈18% revenue in key markets, +12pp EBITDA margin.
| Segment | 2024 metric |
|---|---|
| Combustible | ~60% revenue |
| Modern nicotine | 34% (€6.3bn/€18.5bn) |
| Heated tobacco | ~10% revenue |
| Pouches | ~15% share; $1.1bn |
| Premium | ~18% rev; +12pp EBITDA |
Cost Structure
Raw Material and Sourcing Costs
Procurement of tobacco leaf, nicotine and e-cigarette components makes up a material share of BAT's operating costs-BAT reported cost of sales of £19.2bn in FY2024, with commodities and input inflation cited as key drivers; commodity price swings and supply – chain pressure can raise COGS by several percent. BAT mitigates exposure via multi – year supplier contracts and currency/commodity hedges; in 2024 BAT disclosed hedging covering a portion of expected input volumes through 2025.
Manufacturing and Operational Overheads
Running BAT's global factory network drives major costs in labor, energy and maintenance; in 2024 BAT reported manufacturing and distribution costs of £6.3bn, and energy bought rose ~7% year-on-year. BAT is trimming these via £350m+ capital spend on factory automation and energy-efficiency projects between 2023-2025, improving throughput and lowering unit costs; operational efficiency remains a core KPI to protect ~22% adjusted operating margin.
Marketing and Distribution Expenses
BAT allocates large capital to brand promotion, retail merchandising and a global distribution network-marketing and distribution costs were about £2.8bn in 2024, supporting brand equity and shelf availability in >180 markets. Spend is shifting to digital and New Category launches (RRPs, vaping, nicotine pouches), with digital marketing up ~18% YoY and New Category investment rising to ~15% of total marketing in 2024.
Research and Development Investment
BAT spends c.£400-500m annually on R&D into reduced-risk products (RRP), covering scientific studies, clinical trials, and hardware/consumables engineering, with capital and operating costs split across labs, trials, and product development.
Management treats this as a strategic, long-term cost to sustain revenue as combustible-tobacco declines; R&D outlays rose ~8% in 2024 versus 2023 as RRP pipeline expanded.
- £400-500m annual R&D
- Includes trials, studies, engineering
- 8% R&D increase in 2024 vs 2023
- Classified as long-term strategic spend
Excise Taxes and Regulatory Levies
Tobacco faces some of the world's highest excise taxes; BAT reported excise and similar taxes of $22.1bn in 2024, so shifts in tax rates directly alter shelf prices and demand elasticity, forcing SKU and pricing changes across markets.
BAT also incurs ongoing compliance, litigation, and IP defense costs-legal and regulatory expenses rose to $1.2bn in 2024-adding fixed overhead and downside risk to margins.
- 2024 excise taxes: $22.1bn
- 2024 legal/regulatory costs: $1.2bn
- Tax changes → immediate price, demand effects
- IP defense adds recurring fixed cost
BAT cost structure: £17.8bn taxes, £25.5bn production, rising automation & R&D
BAT's largest costs are excise taxes (£≈17.8bn in 2024), cost of sales (£19.2bn) and manufacturing/distribution (£6.3bn); R&D for reduced – risk products runs £400-500m annually and legal/regulatory costs were $1.2bn in 2024, with £350m+ capex on factory automation (2023-25) reducing unit costs.
| Item | 2024 amount |
|---|---|
| Cost of sales | £19.2bn |
| Manufacturing & distribution | £6.3bn |
| Excise taxes | $22.1bn (~£17.8bn) |
| R&D (RRP) | £400-500m |
| Legal/regulatory | $1.2bn |
| Automation capex (2023-25) | £350m+ |
Revenue Streams
Sales of Combustible Tobacco Products
Traditional cigarettes remain BAT's primary revenue and cash driver through end-2025, accounting for about 58% of group net revenue (£19.6bn of £33.8bn in 2025), with growth backed by a mix of modest volume gains and price increases, especially in EMs where consumption stayed resilient. High EBIT margins (~36% on combustible in 2025) fund R&D and capex for next – gen products.
Vapour Product Sales
Vuse (BAT) now drives a fast-growing vapour revenue stream, with NGP (next-generation products) vaping net revenue rising 28% to £2.3bn in 2024, reflecting device sales plus recurring, high-margin liquid pod sales; pods account for ~65% of unit volumes and underpin gross margins ~40-50%. Growth is led by market-share gains in the US and Europe, where Vuse reached roughly 12%-15% share in 2024 in key channels.
Heated Tobacco Product Sales
Glo device sales and consumable Neostiks (tobacco sticks) drive this revenue stream; BAT reported heated tobacco net revenue of £2.1bn in FY2024, up ~12% year-on-year, reflecting strong repeat purchases under a razor-and-blade model. Glo performs especially well in Japan and Eastern Europe where market share often exceeds 30% in select channels, yielding higher per-user lifetime value than combustible products.
Modern Oral Nicotine Sales
The Velo nicotine-pouch brand is a high-growth revenue stream for British American Tobacco, with global pouch volumes rising ~25% in 2024 and pouches contributing an estimated £600m+ in retail sales that year.
Lower per-unit manufacturing costs versus heated devices yield gross margins near 40-50%, and geographic expansion (entered 10+ new markets 2022-24) drives continued topline growth.
- 2024 pouch volume growth ~25%
- Estimated 2024 retail sales £600m+
- Gross margins ~40-50%
- Entered 10+ new markets 2022-24
Licensing and Intellectual Property Income
BAT earns secondary revenue by licensing brands and patented nicotine-delivery tech to third parties, generating royalty income-reported as part of other operating income in 2024 at roughly £150-200m annually, lower than product sales but with gross margins above 70% and minimal capex.
- Royalty income: ~£150-200m (2024 estimate)
- Gross margin: >70%
- Low operational overhead, minimal capex
- Strategic in markets where direct sales are limited
BAT 2025: Combustible 58% (£19.6bn) as NGPs rise-vape/heated ~£4.4bn, royalties >70%
BAT's 2025 net revenue mix: combustible ~58% (£19.6bn/£33.8bn), NGP vapour £2.3bn (2024, +28%), heated tobacco £2.1bn (2024, +12%), pouches ~£600m (2024, +25% vol), royalties £150-200m (2024); combustible EBIT margin ~36%, NGP/heated gross margins ~40-50%, royalties >70%.
| Stream | 2024/25 | Revenue | Margin |
|---|---|---|---|
| Combustible | 2025 | £19.6bn | ~36% EBIT |
| Vape (Vuse) | 2024 | £2.3bn | 40-50% |
| Heated (Glo) | 2024 | £2.1bn | 40-50% |
| Pouches (Velo) | 2024 | £600m+ | ~40-50% |
| Royalties | 2024 | £150-200m | >70% |
Frequently Asked Questions
Yes, it is built specifically for British American Tobacco and its tobacco and nicotine portfolio. This research-backed company analysis turns public information into a presentation-ready Business Model Canvas, helping you understand how it creates, delivers, and captures value across combustibles, vapour, heated tobacco, and modern oral products.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.